GLP1R and medullary thyroid gland carcinoma: Indeed, concerns have emerged regarding a potential adverse association between GLP‐1 RAs and medullary thyroid cancer, largely based on rodent studies, where liraglutide and exenatide were linked to the development of thyroid C‐cell tumors at supratherapeutic doses.40, 41